A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors

NCT07165067 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: AP601

Sponsor

AP Biosciences Inc.

Collaborators

Avance Clinical Pty Ltd.